M&A

Capricor Therapeutics (CAPR) Files Form 144 on May 19

Published on 5/19/2026

#CAPR#Form144#securities
Capricor Therapeutics (CAPR) Files Form 144 on May 19

AI Summary

Summarized by AI from the source below

Capricor Therapeutics (CAPR) submitted Form 144 on May 19, indicating the intention to sell shares for a specified amount. This filing is a regulatory requirement for sellers of restricted securities. The document helps investors understand potential selling pressure on the stock. Such transactions may impact trading volumes and share price.

Share:
Source: Read original article (opens in new tab)

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.

Related News

Trump Accounts Launch for Eligible Newborns with $1K Investment
M&A

Trump Accounts Launch for Eligible Newborns with $1K Investment

Jul 4

LADR Reports Asset Management Head Sells 35,000 Shares
M&A

LADR Reports Asset Management Head Sells 35,000 Shares

Jul 4

Cerebras Systems (CBRS) IPO Fluctuations: Opened at $350, Now $221
Markets

Cerebras Systems (CBRS) IPO Fluctuations: Opened at $350, Now $221

Jul 4

Next (NXT) Plans Takeover Bid for Harvey Nichols, Reports Sky News
M&A

Next (NXT) Plans Takeover Bid for Harvey Nichols, Reports Sky News

Jul 4